SHANNON HORVATH: Open Payments
NPI 1265820658 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 55 payments from 15 companies in 2025. Trend: 2023 $970 · 2024 $780 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $393 |
| PFIZER INC. | 11 | $165 |
| Ferring Pharmaceuticals Inc. | 2 | $50 |
| Gilead Sciences, Inc. | 3 | $48 |
| GENZYME CORPORATION | 1 | $41 |
| Tempus AI, Inc | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $25 |
| Ardelyx, Inc. | 1 | $23 |
Products named: RINVOQ, SKYRIZI, VELSIPITY, XELJANZ, REBYOTA, MAVYRET, LINZESS, AYVAKIT.
Industry payments across OH — which companies pay providers there.
